Pharnext Logo

Pharnext

ALPHA | Euronext Growth

Overview

Corporate Details

ISIN(s):
FR0011191287 (+4 more)
LEI:
969500KJGF9ZUYXSMJ27
Country:
France
Address:
9 RUE DES FILLES SAINT-THOMAS, 75002 PARIS
Sector:
Health Care
Industry:
Biotechnology

Description

Our company Pharnext is an advanced clinical-stage biopharmaceutical company developing novel therapeutics for neurodegenerative diseases with high unmet medical needs. Our drug Candidates Two drug candidates are currently in clinical development: PXT3003 for the treatment of Charcot-Marie-Tooth disease type 1A and PXT864 for Alzheimer’s disease. Both of our lead assets originated from the Pleotherapy R&D approach.

Social Media

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2024-08-27 13:00
Regulatory News Service
Ouverture d'une procédure de liquidation judiciaire
French 194.1 KB
2024-08-01 18:00
Inside Information Statement
Ajustement de la valeur nominale
French 189.9 KB
2024-07-18 18:00
Capital/Financing Update
Point concernant l'accord de financement en obligations convertibles accordé pa…
French 194.2 KB
2024-07-15 18:00
Regulatory News Service
Demande d'ouverture d'une procédure de liquidation judiciaire
French 193.2 KB
2024-07-10 08:00
Inside Information Statement
Pharnext fait un point sur sa situation financière
French 191.6 KB
2024-07-04 20:00
Inside Information Statement
Pharnext annonce la résiliation du contrat de financement accordé par Néovacs
French 232.3 KB
2024-07-03 08:00
Regulatory News Service
Pharnext fait un point sur les conséquences de sa situation stratégique et fina…
French 208.2 KB
2024-07-01 18:30
Declaration of Voting Results & Voting Rights Announcements
Information relative au nombre total de droits de vote et d'actions composant l…
French 185.7 KB
2024-06-28 08:00
Inside Information Statement
Pharnext fait un point d'étape sur les dernières avancées majeures d'un point d…
French 209.3 KB
2024-06-18 18:30
Regulatory News Service
Pharnext annonce la prorogation de la procédure de conciliation jusqu'au 15 jui…
French 194.9 KB
2024-06-05 18:30
Declaration of Voting Results & Voting Rights Announcements
Information relative au nombre total de droits de vote et d'actions composant l…
French 181.3 KB
2024-05-29 18:00
Inside Information Statement
Ajustement de la valeur nominale
French 190.9 KB
2024-05-07 19:10
Inside Information Statement
Ajustement de la valeur nominale
French 190.6 KB
2024-05-06 18:00
AGM Report
Pharnext convoque ses actionnaires en assemblée générale le 10 juin 2024
French 194.7 KB
2024-05-02 18:30
Declaration of Voting Results & Voting Rights Announcements
Information relative au nombre total de droits de vote et d'actions composant l…
French 195.4 KB

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
BIG Technologies PLC Logo BIG Technologies PLC United Kingdom BIG
BioArctic Logo BioArctic Sweden BIOA
Bioceltix S.A. Logo Bioceltix S.A. Poland BCX
Bioextrax AB Logo Bioextrax AB Sweden BIOEX
Biofrontera AG Logo Biofrontera AG Germany B8F
BioGaia Logo BioGaia Sweden BIOG
Biohit Oyj Logo Biohit Oyj Finland BIOBV
BioInvent International Logo BioInvent International Sweden BINV
BioLineRx Ltd. Logo BioLineRx Ltd. Israel BLRX
Biophytis S.A. Logo Biophytis S.A. France ALBPS